NYSE:GMED Globus Medical (GMED) Stock Price, News & Analysis $78.98 +3.33 (+4.41%) Closing price 03:59 PM EasternExtended Trading$78.96 -0.02 (-0.03%) As of 04:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Globus Medical Stock (NYSE:GMED) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Globus Medical alerts:Sign Up Key Stats Today's Range$76.17▼$79.2050-Day Range$73.36▼$88.4852-Week Range$59.51▼$101.40Volume1.55 million shsAverage Volume1.48 million shsMarket Capitalization$10.60 billionP/E Ratio20.20Dividend YieldN/APrice Target$99.46Consensus RatingModerate Buy Company Overview Globus Medical, Inc. develops and commercializes musculoskeletal solutions for surgeons, hospitals and patients. The company focuses primarily on spinal, orthopedic trauma and other orthopedic procedures, offering implants, instruments and related technologies designed to support surgical treatment and improve clinical outcomes. Its product portfolio includes spinal implants and enabling technologies, including the ExcelsiusGPS robotic navigation platform and Excelsius3D imaging system. Globus Medical also provides solutions for orthopedic trauma, such as implants and instruments used to treat fractures and other musculoskeletal injuries. Following its combination with NuVasive in 2023, the company expanded its portfolio to include additional spine technologies and surgical solutions. Founded in 2003 and headquartered in Audubon, Pennsylvania, Globus Medical serves healthcare providers in the United States and international markets. The company distributes its products through direct sales and other commercial channels, working with surgeons, hospitals and healthcare systems worldwide.AI Generated. May Contain Errors. Read More Globus Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks87th Percentile Overall ScoreGMED MarketRank™: 4.3578528827 of 5 starsGlobus Medical scored higher than 87% of companies evaluated by MarketBeat, and ranked 63rd out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.4 / 5Analyst RatingModerate Buy Consensus RatingGlobus Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.88, and is based on 3 strong buy ratings, 9 buy ratings, 5 hold ratings, and no sell ratings.Upside PotentialGlobus Medical has a consensus price target of $99.46, representing about 25.9% upside from its current price of $79.01.Amount of Analyst CoverageGlobus Medical has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Globus Medical's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth8.02% Earnings GrowthEarnings for Globus Medical are expected to grow by 8.02% in the coming year, from $4.99 to $5.39 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Globus Medical is 20.21, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.75.Price to Earnings Ratio vs. SectorThe P/E ratio of Globus Medical is 20.21, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.56.Price to Earnings Growth RatioGlobus Medical has a PEG Ratio of 1.24. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioGlobus Medical has a P/B Ratio of 2.33. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Globus Medical's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted7.70% of the float of Globus Medical has been sold short.Short Interest Ratio / Days to CoverGlobus Medical has a short interest ratio ("days to cover") of 5.14.Change versus previous monthShort interest in Globus Medical has recently increased by 24.67%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldGlobus Medical does not currently pay a dividend.Dividend GrowthGlobus Medical does not have a long track record of dividend growth. News and Social Media3.4 / 5News Sentiment0.51 News SentimentGlobus Medical has a news sentiment score of 0.51. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Globus Medical this week, compared to 5 articles on an average week.Search Interest8 people have searched for GMED on MarketBeat in the last 30 days. This is an increase of 14% compared to the previous 30 days.MarketBeat Follows7 people have added Globus Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 133% compared to the previous 30 days. Company Ownership2.1 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Globus Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $4,413,400.00 in company stock.Percentage Held by Insiders18.38% of the stock of Globus Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions95.16% of the stock of Globus Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Globus Medical's insider trading history. Receive GMED Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Globus Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GMED Stock News HeadlinesIs Globus Medical (GMED) Cheap On Its Spine Platform Reveal?October 15, 2026 | finance.yahoo.comGlobus Medical (GMED) Stock Looks Discounted Against Its Earnings OutlookOctober 15, 2026 | finance.yahoo.comThe Iran War Isn’t Chaos. It’s Strategy.Two thousand missiles struck Iran. Three days later, Dylan Jovine sat in two private meetings with U.S. Congressmen no cameras, no staff. What he found afterward points to a coordinated Two-Front Economic War already in motion, according to his research at Behind the Markets.October 20 at 1:00 AM | Behind the Markets (Ad)What Does Globus Medical (GMED) Mean For Spine Care After Its NASS 2026 Reveal?October 15, 2026 | finance.yahoo.comGlobus Medical Showcases Script? Patient-Specific Spinal Implant Platform and Xlif? Prone Procedural Solution At NassOctober 14, 2026 | marketscreener.comMGlobus Medical to Showcase SCRIPT™ Patient-Specific Implants and New XLIF™ Prone Procedural Solution at NASS 2026October 14, 2026 | globenewswire.comGlobus Medical to Announce Third Quarter 2026 Financial Results on November 5 and Hold Conference CallOctober 12, 2026 | quiverquant.comQGlobus Medical Schedules Third Quarter Earnings Release and Conference CallOctober 12, 2026 | globenewswire.comSee More Headlines GMED Stock Analysis - Frequently Asked Questions How have GMED shares performed this year? Globus Medical's stock was trading at $87.39 at the start of the year. Since then, GMED shares have decreased by 9.6% and is now trading at $79.01. How were Globus Medical's earnings last quarter? Globus Medical, Inc. (NYSE:GMED) issued its quarterly earnings results on Thursday, August, 6th. The medical device company reported $1.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.10 by $0.24. The business's quarterly revenue was up 5.9% on a year-over-year basis. Read the conference call transcript. Is Globus Medical buying back stock? Globus Medical's board initiated a stock buyback plan on Thursday, May 15th 2025, which authorizes the company to repurchase $500,000,000 in outstanding shares, according to EventVestor. This means that the company could purchase up to 6.3% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company's leadership believes its stock is undervalued. When did Globus Medical IPO? Globus Medical (GMED) raised $200 million in an initial public offering (IPO) on Friday, August 3rd 2012. The company issued 11,764,705 shares at $16.00-$18.00 per share. Who are Globus Medical's major shareholders? Globus Medical's top institutional shareholders include Artemis Investment Management LLP (0.40%), Fort Washington Investment Advisors Inc. OH (0.34%), Congress Asset Management Co. (0.27%) and Annex Advisory Services LLC (0.02%). Insiders that own company stock include David D Davidar, Stephen T Zarrilli, Ann D Rhoads, James R Tobin, Leslie V Norwalk, Keith W Pfeil, Kelly Huller, Kyle Kline, Dan Lemaitre and Daniel T Scavilla. View institutional ownership trends. How do I buy shares of Globus Medical? Shares of GMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Globus Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Globus Medical investors own include CrowdStrike (CRWD), NVIDIA (NVDA), Trade Desk (TTD), Shopify (SHOP), Tesla (TSLA), Walt Disney (DIS) and Zoom Communications (ZM). Company Calendar Last Earnings8/06/2026Today10/20/2026Next Earnings (Estimated)11/05/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (1m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 GMED's financial health is in the Red zone, according to TradeSmith. GMED has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNYSE:GMED CIK1237831 Webwww.globusmedical.com Phone(610) 930-1800Fax610-930-2042Employees6,000Year Founded2003Price Target and Rating Average Price Target for Globus Medical$99.46 High Price Target$123.00 Low Price Target$80.00 Potential Upside/Downside+25.9%Consensus RatingModerate Buy Rating Score (0-4)2.88 Research Coverage17 Analysts Profitability EPS (Trailing Twelve Months)$3.91 Trailing P/E Ratio20.20 Forward P/E Ratio15.83 P/E Growth1.24Net Income$537.87 million Net Margins17.02% Pretax Margin20.99% Return on Equity14.57% Return on Assets12.62% Debt Debt-to-Equity RatioN/A Current Ratio4.62 Quick Ratio2.93 Sales & Book Value Annual Sales$2.94 billion Price / Sales3.61 Cash Flow$6.47 per share Price / Cash Flow12.21 Book Value$33.86 per share Price / Book2.33Miscellaneous Outstanding Shares134,260,000Free Float109,585,000Market Cap$10.60 billion OptionableOptionable Beta0.96 Social Links The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (NYSE:GMED) was last updated on 10/20/2026 by MarketBeat.com Staff. From Our PartnersTrump’s Plan To Cheat HistoryChina has slashed its U.S. Treasury holdings by more than 45% from their peak, while building gold vaults and ...Porter & Company | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | Sponsored$40,000,000,000,000The national debt just hit 40 trillion dollars, and the U.S. now spends more on interest payments than on its ...American Alternative | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredINSANE DRONE FOOTAGENew drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...Paradigm Press | SponsoredWhy Some AI Stocks Already Surged Over 300 PercentJason Bodner's system flagged Nvidia before a 7000 percent run, Super Micro Computer before a 2600 percent run...Brownstone Research | SponsoredThe Iran War Isn’t Chaos. It’s Strategy.Two thousand missiles struck Iran. Three days later, Dylan Jovine sat in two private meetings with U.S. Congre...Behind the Markets | SponsoredBeginner’s Guide to GoldInflation, trade wars, and market volatility have many savers rethinking how they protect retirement funds. A ...Goldco Direct, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Globus Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Globus Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
